Françoise Solly

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé et al. · Blood Advances · 2019 · 121 citations · Full text

Medicine, Hematology, Oncology +17

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent

Fanny Angelot‐Delettre, Anne Roggy, Arthur E. Frankel et al. · Haematologica · 2014 · 63 citations · Full text

Medicine, Oncology, Pharmacology +11

CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry

Françoise Solly, Fanny Angelot, Richard Garand et al. · Cytometry Part A · 2011 · 41 citations · Full text

Medicine, Hematology, Oncology +17

An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia

Françoise Solly, Catherine Koering, Aminetou Mint Mohamed et al. · Clinical Cancer Research · 2016 · 36 citations

Medicine, Molecular Biology, Oncology +17

Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-Vβ repertoire

Dimitri Salameire, Françoise Solly, Blandine Fabre et al. · Modern Pathology · 2012 · 20 citations · Full text

Life Sciences, Immunology, Oncology +13